Trial Profile
Efficacy and safety of golimumab in patients with ulcerative colitis in clinical practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 08 Mar 2017 New trial record